Melatonin Xl Activase

Melatonin, the active ingredient in Melatonin Xl Activase, is a melatonin receptor agonist presented as an oral formulation for oral use. It is employed to help regulate circadian rhythm and promote sleep onset in adults experiencing insomnia, jet lag, or shift‑work sleep disorder.

GNH USA supplies Melatonin Xl Activase as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics and comprehensive documentation for import compliance.

Melatonin Xl Activase is a melatonin receptor agonist used to address sleep‑related disorders.

- Insomnia: improves sleep onset and reduces nighttime awakenings. - Jet lag: helps synchronize circadian rhythm after rapid time‑zone travel. - Shift work sleep disorder: supports daytime alertness and nighttime sleep in rotating‑shift workers.

Melatonin Xl Activase may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness. - Headache. - Nausea.

Serious or Rare Side Effects: - Allergic reaction (rash, swelling). - Severe hypotension. - Mood changes (depression, anxiety).

When considering Melatonin Xl Activase, several precautionary measures should be observed to ensure safe use.

- Assess underlying sleep disorders: confirm diagnosis before initiating therapy. - Avoid use in children without specialist advice: pediatric safety not established. - Review concomitant medications: potential interactions may alter melatonin levels. - Monitor for excessive sedation: advise patients not to operate machinery if drowsy. - Pregnancy and lactation: use only if benefits outweigh risks after professional evaluation. - Store at ambient temperature: keep below 25 °C in original container, protect from moisture and light.

Melatonin Xl Activase can interact with other agents that influence the central nervous system or melatonin metabolism.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines, barbiturates): may increase sedation. - Anticoagulants (e.g., warfarin): melatonin may potentiate anticoagulant effect. - Immunosuppressants (e.g., cyclosporine): possible alteration of drug levels.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluvoxamine): can raise melatonin concentrations. - Antihypertensive agents: melatonin may enhance blood‑pressure‑lowering effect. - Oral contraceptives: may increase melatonin plasma levels.